Trials / Active Not Recruiting
Active Not RecruitingNCT06468956
Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of SHR-1819 Injection in Patients With Moderate to Severe Atopic Dermatitis
- Status
- Active Not Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 652 (actual)
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This trial was designed to evaluate the efficacy and safety of SHR-1819 injection in patients with atopic dermatitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR-1819 | SHR-1819 injection |
| DRUG | Placebo | placebo |
Timeline
- Start date
- 2024-06-14
- Primary completion
- 2026-03-31
- Completion
- 2026-03-31
- First posted
- 2024-06-21
- Last updated
- 2025-09-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06468956. Inclusion in this directory is not an endorsement.